Nova MD review

Use the total and the selected pharmacy together

Semaglutide + B12 is $175 billed monthly or $387 quarterly, equivalent to $129 per month. Tirzepatide is $199 monthly. Its quarterly choices show Drug Crafters at $387 and Southend/Vials RX at $447; the $467 NewLife option is marked temporarily paused. The headline does not establish a universally available $129 month-to-month plan. ^{[1] [2]}

The selected Drug Crafters panel names B12 or glycine and lists state exclusions. Selecting Southend/Vials RX reveals Southend’s B6 formulation and restrictions, alongside a separate Vials RX B12-and-glycine description. These are different preparations and access conditions. Confirm the actual selected dispenser and label, rather than transfer the cheapest quote across pharmacies. ^[2]

Align the selected pharmacy, charge and payment period in the GLP-1 total-cost planner.

Included care does not settle the full formulation

Nova lists consultation, care, medication, supplies, shipping and support. Its description tabs identify injected treatment, while portal chat and follow-ups provide continuing contact. The public product cards do not establish the complete active quantity and concentration for every GLP-1 order or a universal included laboratory panel. ^{[1] [2]}

The policy permits pharmacy changes at renewal when production pauses, with routing to an available state option and notification. A customer cannot assume the same additive or dispenser will always continue. A pharmacy name or logo also does not establish a particular batch’s quality. ^[3]

Compare a different coaching and monitoring description in our LaSara care-scope review.

Approval protects the initial charge; filling limits the exit

The policy says an authorization hold becomes a charge only after medical approval. If treatment is not approved, the hold is released; bank timing may vary. Before pharmacy filling, an approved cancellation may retain $25 for a completed consultation. Filled medication generally cannot be exchanged even for another additive, quantity or pharmacy. ^[3]

Stop future renewals at least forty-eight hours before billing. A timely unprocessed cancellation has a stated renewal-refund remedy. Damaged or incorrectly fulfilled medication needs a report within forty-eight hours of delivery for review. The delay provisions use both ten days and ten business days; clarify the applicable nonshipment refund rather than infer a general return window. ^{[3] [4]}

For another conditional cancellation agreement, read the Telezen MD refund review.

Compare another prescription service with a different cancellation boundary in our Näky care-and-commitment review.

An additive is not an approval or outcome shortcut

Compounded preparations are not FDA-approved generic equivalents. FDA’s current compounding conditions remain patient-specific after shortages resolve; adding B12 does not by itself establish that a preparation satisfies those conditions or improves treatment results. Clinical suitability belongs with the prescribing professional. ^{[5] [6]}

I would compare Nova on the actual preparation, follow-up and payment commitment. Testimonials and illustrative weight-change ranges are not results established for this supplied prescription. A monthly plan costs more per advertised month but may be the clearer financial commitment while the ongoing treatment arrangement is being settled. ^{[1] [2] [3]}

Keep clinical outcomes separate from a low headline with the GLP-1 body-composition evidence.

Understanding the cost

Semaglutide $175/month or $387 quarterly ($129 equivalent). Tirzepatide $199/month; Drug Crafters quarterly $387, Southend/Vials RX $447. NewLife $467 quarterly marked temporarily paused. Pharmacy/state eligibility applies. Confirm exact formulation, quantity, selected invoice and renewal.